Lapakast -250 mg
Molecular Salt: Lapatinib Ditosylate IP -250mg
Composition: It contains Lapatinib Ditosylate IP 250 mg
Classification: Oncology Medicine
What is Lepakast?
Targeted therapy anticancer medicine, widely used for breast cancers, early stages or the advanced cancers.
Uses of Lepakast -
Advanced-stage Breast cancer
Metastatic Breast Cancer
Lung cancer
How does Lepakast work?
It inhibits signals for cancer cell growth and division, causing cancer cells to die.
Shrinks the breast tumor
Slow down cancer progression
Most Common Side Effects
Anorexia
Diarrhea
Skin rashes, itchiness
Stomatitis, constipation, and abdominal pain
Palmar-plantar erythrodysaesthesia
Pain in the extremity, back pain
Alopecia
Serious side-effects
Bleeding
Dehydration
QT prolongation
Hand and foot syndrome
Reduces potassium and magnesium levels
Toxicities
Cardiac toxicities
Hepatotoxicity
Interstitial Lung Disease
Pneumonitis
Contraindications
Not to be used in patients -
Any allergy to the drug composition.
Lactating women
Pregnant women
Precautions
To be used cautiously in patients with
Heart disease
Liver disease
Blood disorders
Warnings
To be used under medical supervision
Important Safety and Monitoring Information
Regular monitoring is crucial for patient safety and treatment efficacy -
The liver function, cardiac function, electrolyte balance, hydration status, and blood count.
Aprazer Healthcare
Tablets (250mg)
Single Pack Unit
Store below 30°C
Product Enquiry
Submit an enquiry for wholesale sourcing, pricing, and cold-chain delivery. Our team responds within 24 hours.
Clinical Advisory & Import Compliance
Disclaimer: Gandhi Medicos is a clinical specialty supplier and exporter. All enquiries are subject to valid licensing verification and import permits standard under target jurisdiction guidelines.
Storage Warning: Biological injectables, biosimilars, and active oncology agents are flagged as temperature-sensitive cargo and are packed strictly inside thermal containers coupled with real-time digital temperature tags.